Epigenetic therapy for post-traumatic epilepsy
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210275
- Recipient
-
Texas A & M University System Health Science Center UEI HFT7XTHB6563 Part of The Texas A&M University System
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $745,304
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Bryan, TX 77807, USA
Award details come from USAspending.gov.
About this award
The Department of the Army Medical Command awarded $745,304 to Texas A&M University Health Science Center under the Military Medical Research and Development program (CFDA 12.420) to support the project "Epigenetic Therapy for Post-Traumatic Epilepsy" from September 30, 2022 through September 29, 2025. The project aims to develop innovative medical solutions for traumatic brain injury through basic, applied, and advanced biomedical research investigating epigenetic approaches to treat post-traumatic epilepsy in military service members and civilians. Texas A&M University Health Science Center will leverage its expertise in neuroscience and epigenetics to conduct the proposed research and help transform military and civilian healthcare by developing new treatment options for those suffering from epilepsy following traumatic brain injury.
Quick answers
Who received award W81XWH2210275?
W81XWH2210275 was awarded to Texas A & M University System Health Science Center by Medical Command (Department of the Army) on September 30, 2022.
How much is award W81XWH2210275 worth?
$745,304 has been obligated on W81XWH2210275.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award